Antibody-Drug Conjugation Conjugate drugs directly to your antibody of choice. Produce conjugates with defined antibodydrug ratios. Features High Potency ADCs Rapid ADC prototyping: 30 seconds hands on time Site-specific labeling ensures homogenous ADCs oYo-Link DM1 is an antibody-drug conjugation reagent enabling sitespecific labeling of compatible antibodies with up to two DM1 drugs per antibody for subsequent cell killing assays or other RUO drug delivery applications. oYo-Link VcMMAE is an antibody-drug conjugation reagent enabling sitespecific labeling of compatible antibodies with up to two VcMMAE drugs per antibody for subsequent cell killing assays or other RUO drug delivery applications.. oYo-Link VcMMAF is an antibody-drug conjugation reagent enabling sitespecific labeling of compatible antibodies with up to two VcMMAF drugs per antibody for subsequent cell killing assays or other RUO drug delivery applications. To get a quote for the products or to place an order, please email Sales@2BScientific.com.